Jefferies Maintains Buy on NuCana, Lowers Price Target to $3
Jefferies analyst Eun Yang maintains NuCana (NASDAQ:NCNA) with a Buy and lowers the price target from $21 to $3.
NuCana Presents Data On NUC-7738 At The European Society Of Medical Oncology Annual Meeting 2022
NUC-7738 Demonstrates Encouraging Anti-Tumor Activity and a Favorable Safety Profile Across a Variety of Solid Tumors
NUC-7738 Monotherapy and Combination with Pembrolizumab to be Investigated in Phase 2
PARIS,
NuCana Presents Data On NUC-3373 At The European Society Of Medical Oncology Annual Meeting 2022
NUC-3373 Demonstrates Promising Anti-Tumor Activity and Safety in Combination with Oxaliplatin (NUFOX) and Irinotecan (NUFIRI) in Heavily Pre-Treated Colorectal Cancer Patients
Randomized Study of NUFIRI vs.
NuCana Granted U.S. Patent Titled ‘Cancer treatments’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11400107.PN.&OS=PN/11400107&RS=PN/11400107
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.
